Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:March 3, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:March 3, 2020Completed
Condition(s):Fanconi’s Anemia; PancytopeniaLast Updated:July 2, 2017Completed
Condition(s):Brain and Central Nervous System TumorsLast Updated:June 27, 2018Completed
Condition(s):Fanconi AnemiaLast Updated:June 23, 2017Completed
Condition(s):Heart Failure Congestive; Ischemic Cardiomyopathy; Non-ischemic CardiomyopathyLast Updated:August 29, 2017Terminated
Condition(s):Duchenne Muscular DystrophyLast Updated:February 22, 2024Recruiting
Condition(s):Retinitis PigmentosaLast Updated:November 28, 2023Enrolling by invitation
Condition(s):Prostate CancerLast Updated:April 18, 2023Terminated
Condition(s):Ovarian Cancer; Peritoneal Cavity CancerLast Updated:February 2, 2021Completed
Condition(s):HIV-1Last Updated:December 12, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.